RIDGEWATER, N.J. — Bausch + Lomb announced that LUMIFY brimonidine tartrate ophthalmic solution 0.025% redness reliever eye drops were named a Product Showcase winner in the healthcare and over-the-counter (OTC) category at the National Association of Chain Drug Stores’ (NACDS) 2018 Total Store Expo.
“We’re honored to be recognized by NACDS with the coveted Product Showcase award for LUMIFY, because it demonstrates that our retail customers and their customers see the value delivered by this new product,” said Joe Gordon, U.S. president, Bausch + Lomb. “Within three months of launching, LUMIFY is already the number one doctor recommended brand of redness reliever eye drops and has already reached a market share of over 20% share of the redness reliever category. We remain committed to bringing new and unique products like LUMIFY to market that meet the evolving needs of consumers.”
LUMIFY is the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate 0.025% for the treatment of ocular redness. In clinical trials, LUMIFY demonstrated a strong safety and efficacy profile with low risk for rebound redness and 95% symptom improvement seen at one minute that lasts up to eight hours.
LUMIFY was one of 10 other products recognized by NACDS as Product Showcase winners in categories that included baby care, consumables, home healthcare, personal care and pharmacy products.
For the full list of Total Store Expo Product Showcase winners, click here.